Please login to the form below

Not currently logged in
Email:
Password:

Pemphis vulgaris

This page shows the latest Pemphis vulgaris news and features for those working in and with pharma, biotech and healthcare.

GSK unit takes new ofatumumab formulation into phase III

GSK unit takes new ofatumumab formulation into phase III

The trial in patients with pemphigus vulgaris, a serious condition in which patients develop painful blisters in the mouth and on the skin that can become infected. ... At the moment the standard treatment for pemphigus vulgaris - which affects around

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change
...

Infographics